P. Ho

Regulation of transferrin receptor in myeloid and monocytic differentiation of HL-60 leukemia cells.

A. Sartorelli, K. Ishiguro, P. Ho, 1989, Cancer research.

Transcriptional regulation of the transferrin receptor in differentiating HL-60 leukemic cells.

A. Sartorelli, I. King, P. Ho, 1986, Biochemical and biophysical research communications.

Precision Engineering of an Anti-HLA-A2 Chimeric Antigen Receptor in Regulatory T Cells for Transplant Immune Tolerance

J. Bluestone, F. Claas, V. Nguyen, 2021, bioRxiv.

Non-sequence-specific inhibition of transferrin receptor expression in HL-60 leukemia cells by phosphorothioate oligodeoxynucleotides.

E. Wickstrom, A. Sartorelli, K. Ishiguro, 1991, Antisense research and development.

The regulation of the transferrin receptor by inducers of cellular differentiation and by antisense phosphorothioate oligodeoxynucleotides

P. Ho, 1990 .

The CD28-Transmembrane Domain Mediates Chimeric Antigen Receptor Heterodimerization With CD28

J. Bluestone, A. Marson, Theodore L. Roth, 2020, bioRxiv.

Activation of MAP-2 kinase activity by the CD2 receptor in Jurkat T cells can be reversed by CD45 phosphatase.

A. Nel, J. Ledbetter, B. Akerley, 1991, Immunology.

Characterization of the defect in a variant of HL-60 promyelocytic leukemia cells with reduced transferrin receptor expression

A. Sartorelli, K. Ishiguro, P. Ho, 1992, Somatic cell and molecular genetics.

Anti‐HLA‐A2‐CAR Tregs prolong vascularized mouse heterotopic heart allograft survival

Yani Peng, Q. Tang, J. Wagner, 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.